NK1.1Ab treatment partially reverses the CCP-evoked elimination of CD133(+) GBM stem cells and CD68
high GBM cells. The GBM tumor in each mouse was cut into two parts and processed for IHC and Flow Cytometry, respectively.
a-
b IHC: the Vehicle-treated mouse GBM sections harbored a significant number of CD133(+) GBM stem cells (red) (
a first row). Compared to the Vehicle-treated, the CD133(+) fluorescence showed a 72% decrease in the CCP-treated (
*p = 6.5 × 10
− 3 CCP versus Vehicle) (
a, second row and
b) and a 41% decrease in the CCP + NK1.1-treated mice (
a third row and
b) (Δ
p < 0.02, CCP + NK1.1 versus CCP; **
p = 0.03, CCP + NK1.1 versus Vehicle). (Scale bar: 47.62 μm).
c-
f Flow Cytometry: compared to the Vehicle-treated, the CD133(+) cells (
c, top, red circle) were suppressed by 81% in the CCP-treated (
c middle and CD133 IF shown in
d) (*
p < 0.05, CCP versus Vehicle) and by 32% in the CCP + NK1.1 mice (
c, bottom, and
d) (Δ
p < 0.03, CCP + NK1.1 versus CCP; **
p = 3.0 × 10
− 3, CCP + NK1.1 versus Vehicle).
e The fluorescence profiles of the CD133(+) cells in the Vehicle, CCP, and CCP + NK1.1 samples.
f-
h The GBM cells were also probed for CD68, and active-caspase-3 (Act. Cspse 3).
f i In the Vehicle-treated, two segregated populations of CD68(+) but Cspse3(−) cells were identified (Lower Right, LR). The larger population (shown within the blue circle) was CD68
high (presumably GBM cells) whereas a smaller population (shown within the green circle) was CD68
low (expected to be the TAM) [
8,
10,
18]. A very small population of CD68(+), Act. Cspse3(+) (double positive) cells was identified in the upper right (UR) quadrant (within the red ellipse).
f ii In the CCP-treated, CD68
high cells showed an 1187% increase in Act. Cspse 3 IF (red ellipse in the UR quadrant) with respect to Vehicle, along with the virtual disappearance of the CD68
high but Cspse3(−) cells in the blue circle in the LR quadrant (*
p = 0.036, CCP versus Vehicle) (
f ii and
g). The Act. Cspse 3 IF increased by 343% in the CCP + NK1.1 samples, along with the reappearance of some CD68
hgh but Act. Cspse 3(−) cells in the blue circle in the LR quadrant (
f iii and
g) (Δ
p < 0.04, CCP versus CCP + NK1.1; **
p = 3.1 × 10
− 3, CCP + NK1.1 versus Vehicle). (
f iv) Fluorescence profiles for Act.Cspse 3. The CD68 fluorescence in CD68
low cells (TAM) was not significantly different in the three groups (
h). The graphs represent mean ± S.D. obtained from mice treated with Vehicle (
n = 4), CCP (
n = 4), and CCP + NK1.1 (
n = 3)